Advertisement Akorn signs supply agreement for OTC products - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Akorn signs supply agreement for OTC products

Specialty pharmaceuticals company Akorn has announced the signing of a five-year commercial manufacturing and supply agreement with a US ophthalmic company.

Under the terms of the five-year agreement, Akorn will be responsible for the exclusive manufacturing and supply of three OTC eye care products. The line of products will be manufactured at the company’s Decatur, Illinois production facility and are targeted for distribution in the US and world wide markets.

Arthur Przybyl, Akorn’s president and CEO, said: “This partnership reflects company’s strong commitment to bringing high quality contract manufacturing services to the ophthalmic industry. We look forward to working closely with our partner to commercialize their OTC line of products.”